The COVID crisis has given AI a chance to shine for medical researchers this year—and shine it has, judging by one prominent center’s experience.

Some are calling on the agency to boost proposed payments for a tool that diagnoses diabetic retinopathy in order to encourage widespread adoption.

The neuroradiologist and fellow of Stanford’s Hoover Institution labeled fellow coronavirus counselor Anthony Fauci a "political animal" in a recent interview. 

A new AI tool can accurately separate the patients who would do better getting restorative sleep till morning from those who, due to unstable condition, really need their vital signs checked overnight.

Results from the 30,000-patient CArdioPulmonary BioImage Study were presented during the American Heart Association's virtual meeting.

Both supplements are still perfectly safe for patients to take for other reasons, researchers emphasized. 

Anticoagulation therapies are an important part of treating COVID-19 patients—but there appears to be no benefit to taking a more aggressive approach.

RSNA tallied more than 170 self-identified image analysis companies at last year's annual meeting, with that figure only expected to grow.

Patient outcomes are much better when clinicians use single-vessel FFR measurements to determine whether or not to perform PCI. 

Henry Ford providers recently detailed the rare case of a 70-year-old woman who developed a large nodule four years after the procedure.